MedMira Inc.

Equities

MIR

CA58501R1029

Advanced Medical Equipment & Technology

Market Closed - Toronto S.E. Other stock markets 20:57:55 22/05/2024 BST			5-day change	1st Jan Change
0.09 ^CAD	-5.26%		-5.26%	-18.18%

04-02	MedMira Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	CI
03-27	Samsung Pay to stop working with Russia's Mir payment system from April 3	RE

MedMira Inc. Elects Dr. Shou-Ching Tang to its Board

January 30, 2017 at 11:30 pm

MedMira Inc. held its 2017 annual general meeting of shareholders on January 27, 2017. Dr. Shou-Ching Tang who retired as a Director in 2014, was elected to the Board during the meeting held in Halifax, Nova Scotia.

Latest news about MedMira Inc.

MedMira Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	04-02	CI
Samsung Pay to stop working with Russia's Mir payment system from April 3	03-27	RE
MedMira Says Received Canadian Patent for its Quantitative Diagnostic System	03-13	MT
MedMira Brief: Says Received Canadian Patent for its Quantitative Diagnostic System	03-13	MT
MedMira's Fiscal Q1 Loss Widens, Revenue Drops	01-02	MT
MedMira Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023	12-28	CI
U.S. FDA Approves MedMira's Advanced Reveal G4 Rapid HIV-1/2 Antibody Test	12-14	CI
MedMira Inc. Reports Earnings Results for the Full Year Ended July 31, 2023	11-27	CI
Medmira Inc. Provides Update on Its Progress to Achieve Regulatory Approval in Canada and the USA for Its Infectious Disease Rapid Tests	28/09/23	CI
MedMira's Fiscal Q3 Loss Widens, Revenue Falls	30/06/23	MT
MedMira Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	28/06/23	CI
MedMira Falls Near 17% As Widens Q2 Net Loss YOY	04/04/23	MT
MedMira Widens Q2 Net Loss YOY	04/04/23	MT
MedMira Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	02/04/23	CI
MedMira Inc. Provides an Update on Its Progress to Achieve Regulatory Approval in Canada for Its Reveal TP Antibody Test	14/03/23	CI
MedMira Enters into Partnership with Maternova for USA and Latin America	21/02/23	MT
Maternova and MedMira Enter Distribution Agreement to Market Rapid Diagnostics for HIV, Syphilis and Hepatitis	20/02/23	CI
MedMira Provides Progress Update	04/01/23	MT
MedMira Reports Wider Fiscal Q1 Loss, Lower Revenue	03/01/23	MT
MedMira Introduces New Product In Direct Response to Rise of Respiratory Syncytial Virus Cases Globally	30/12/22	MT
MedMira Inc. Introduces VYRA TriDemic	30/12/22	CI
MedMira Inc. Reports Earnings Results for the First Quarter Ended October 31, 2022	29/12/22	CI
MedMira Inc. Auditor Raises 'Going Concern' Doubt	28/11/22	CI
MedMira Inc. Reports Earnings Results for the Full Year Ended July 31, 2022	28/11/22	CI
MedMira Inc. Appoints Sam Ratnam as Director of Scientific & Regulatory Affairs	02/10/22	CI

Chart MedMira Inc.

Duration

Period

More charts

Company Profile

MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. The Company is the developer and owner of Rapid Vertical Flow (RVF) Technology. The Company's rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as Human Immunodeficiency Virus (HIV), Syphilis and hepatitis C in just three easy steps. The Company's tests are sold under the Reveal, Multiplo and Miriad brands in global markets. The Company's manufacturing facilities are located in Halifax, Nova Scotia, Canada.

Sector

Advanced Medical Equipment & Technology

Calendar

27/06/2024 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
MEDMIRA INC.	-18.18%	46.19M
THERMO FISHER SCIENTIFIC	+11.31%	226B
DANAHER CORPORATION	+15.50%	198B
INTUITIVE SURGICAL, INC.	+18.83%	142B
BOSTON SCIENTIFIC CORPORATION	+30.38%	111B
SIEMENS HEALTHINEERS AG	+3.04%	65.26B
EDWARDS LIFESCIENCES CORPORATION	+18.31%	54.36B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.96%	50.94B
AGILENT TECHNOLOGIES, INC.	+9.95%	44.8B
GE HEALTHCARE TECHNOLOGIES INC.	+4.27%	36.8B

Other Advanced Medical Equipment & Technology